TickerFacts.

A business in context

TLSI research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-25 · 8004 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-09-22 · 0001628280-26-063031 · Items 8.01,9.01

  2. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001628280-26-054275

  3. 8-K · Current report

    Report date 2026-08-06 · 0001628280-26-054264 · Items 2.02,9.01

  4. 4 · Ownership change

    Report date 2026-07-01 · 0001628280-26-047217

  5. 4 · Ownership change

    Report date 2026-06-30 · 0001628280-26-046519

  6. 4 · Ownership change

    Report date 2026-06-30 · 0001628280-26-046507

  7. 4 · Ownership change

    Report date 2026-06-29 · 0001628280-26-046015

  8. 4 · Ownership change

    Report date 2026-05-15 · 0001628280-26-036427

  9. 4 · Ownership change

    Report date 2026-05-15 · 0001628280-26-035996

  10. 4 · Ownership change

    Report date 2026-05-15 · 0001628280-26-035995

  11. 4 · Ownership change

    Report date 2026-05-15 · 0001628280-26-035994

  12. 8-K · Current report

    Report date 2026-05-14 · 0001628280-26-035068 · Items 5.07

  13. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001628280-26-034100

  14. 8-K · Current report

    Report date 2026-05-12 · 0001628280-26-034082 · Items 2.02,9.01

  15. 8-K · Current report

    Report date 2026-04-24 · 0001628280-26-028425 · Items 5.02

  16. 8-K · Current report

    Report date 2026-04-01 · 0001628280-26-023991 · Items 5.02,7.01,9.01

  17. DEF 14A · Proxy statement

    Report date 2025-12-31 · 0001628280-26-022124

  18. 10-K · Annual report

    Report date 2025-12-31 · 0001628280-26-015163

  19. 8-K · Current report

    Report date 2026-03-05 · 0001628280-26-015155 · Items 2.02,9.01

  20. 8-K · Current report

    Report date 2026-02-19 · 0001493152-26-007598 · Items 1.01,8.01,9.01

  21. 8-K · Current report

    Report date 2026-02-03 · 0001628280-26-006219 · Items 5.02,7.01,9.01

  22. 8-K · Current report

    Report date 2026-01-12 · 0001628280-26-001743 · Items 2.02,9.01

  23. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001628280-25-052043

  24. 8-K · Current report

    Report date 2025-11-13 · 0001628280-25-052008 · Items 2.02,9.01

  25. 8-K · Current report

    Report date 2025-09-30 · 0001628280-25-043440 · Items 5.02

  26. 8-K · Current report

    Report date 2025-08-25 · 0001826667-25-000129 · Items 5.02

  27. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001826667-25-000117

  28. 8-K · Current report

    Report date 2025-08-12 · 0001826667-25-000115 · Items 2.02,9.01

  29. 8-K · Current report

    Report date 2025-07-24 · 0001826667-25-000103 · Items 3.03,5.03,5.07,8.01,9.01

  30. 8-K · Current report

    Report date 2025-06-23 · 0001826667-25-000077 · Items 8.01,9.01

  31. 8-K · Current report

    Report date 2025-06-12 · 0001826667-25-000074 · Items 5.07

  32. 8-K · Current report

    Report date 2025-05-23 · 0001826667-25-000071 · Items 5.02,8.01,9.01

  33. 10-K/A · Annual report

    Report date 2024-12-31 · 0001826667-25-000070

  34. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001826667-25-000051

  35. 8-K · Current report

    Report date 2025-05-15 · 0001826667-25-000049 · Items 2.02,9.01

  36. DEF 14A · Proxy statement

    Report date 2025-06-12 · 0001826667-25-000040

  37. 8-K · Current report

    Report date 2025-04-30 · 0001104659-25-041862 · Items 1.01,2.02,3.02,7.01,9.01

  38. 8-K · Current report

    Report date 2025-04-20 · 0001826667-25-000036 · Items 5.02

  39. 8-K · Current report

    Report date 2025-04-16 · 0001826667-25-000033 · Items 5.02

  40. 10-K · Annual report

    Report date 2024-12-31 · 0001826667-25-000030

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-22 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 6 transaction rows6PSale: 1 transaction rows1SGrant / award: 19 transaction rows19AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

30 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-29
2026-06-29
Marshall Richard HenryA · Grant / award
Acquired
Common Stock60000.00.0
2026-06-29
2026-06-29
Marshall Richard HenryA · Grant / award
Acquired
Employee Stock Option (right to buy)
Derivative security
120000.00.0
2026-05-15
2026-05-19
Marshak RichardS · Sale
Disposed
Common Stock543.02.67
2026-05-15
2026-05-18
Wahlstrom MatsP · Purchase
Acquired
Common Stock60000.02.53
2026-05-15
2026-05-18
Stansky Michael PP · Purchase
Acquired
Common Stock410000.02.5
2026-05-15
2026-05-18
Stansky Michael PP · Purchase
Acquired
Common Stock200000.02.5
2026-05-15
2026-05-18
Szela Mary TP · Purchase
Acquired
Common Stock39682.02.59
2026-05-15
2026-05-18
Patience DavidP · Purchase
Acquired
Common Stock7100.02.43
2026-05-15
2026-05-18
Gordon Gary B.P · Purchase
Acquired
Common Stock10000.02.46
2026-05-14
2026-05-15
HICKS KERRY RA · Grant / award
Acquired
Common Stock28201.00.0
2026-05-14
2026-05-15
HICKS KERRY RA · Grant / award
Acquired
Director Stock Option (right to buy)
Derivative security
56403.00.0
2026-05-14
2026-05-15
Wahlstrom MatsA · Grant / award
Acquired
Common Stock37602.00.0
2026-05-14
2026-05-15
Wahlstrom MatsA · Grant / award
Acquired
Common Stock34226.00.0
2026-05-14
2026-05-15
Wahlstrom MatsA · Grant / award
Acquired
Director Stock Option (right to buy)
Derivative security
75204.00.0
2026-05-14
2026-05-15
Gordon Gary B.A · Grant / award
Acquired
Common Stock24553.00.0
2026-05-14
2026-05-15
Gordon Gary B.A · Grant / award
Acquired
Common Stock28201.00.0
2026-05-14
2026-05-15
Gordon Gary B.A · Grant / award
Acquired
Director Stock Option (right to buy)
Derivative security
56403.00.0
2026-05-14
2026-05-15
MATLIN DAVID JA · Grant / award
Acquired
Common Stock23065.00.0
2026-05-14
2026-05-15
MATLIN DAVID JA · Grant / award
Acquired
Common Stock28201.00.0
2026-05-14
2026-05-15
MATLIN DAVID JA · Grant / award
Acquired
Director Stock Option (right to buy)
Derivative security
56403.00.0
2026-05-14
2026-05-15
Valle WilliamA · Grant / award
Acquired
Common Stock28201.00.0
2026-05-14
2026-05-15
Valle WilliamA · Grant / award
Acquired
Common Stock24553.00.0
2026-05-14
2026-05-15
Valle WilliamA · Grant / award
Acquired
Director Stock Option (right to buy)
Derivative security
56403.00.0
2026-05-14
2026-05-15
Stansky Michael PA · Grant / award
Acquired
Common Stock20089.00.0
2026-05-14
2026-05-15
Stansky Michael PA · Grant / award
Acquired
Common Stock23501.00.0
2026-05-14
2026-05-15
Stansky Michael PA · Grant / award
Acquired
Director Stock Option (right to buy)
Derivative security
47003.00.0
2025-07-31
2026-04-20
Frankenius Equity ABC · Conversion
Acquired
Common Stock759000.00.0
2025-07-31
2026-04-20
Frankenius Equity ABC · Conversion
Disposed
Series A Convertible Preferred Stock
Derivative security
230000.00.0
2025-07-31
2026-04-01
MATLIN DAVID JC · Conversion
Acquired
Common Stock330000.00.0
2025-07-31
2026-04-01
MATLIN DAVID JC · Conversion
Disposed
Series A Preferred Stock
Derivative security
100000.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-22 · 1612 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001826667TriSalus Life Sciences, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-22 · 1177 checked identities; 0 unavailable records

Search names and former names
  • MedTech Acquisition Corp · former SEC name · 2020-11-30 to 2023-08-10
  • MedTech Acquisition Corporation · former SEC name · 2020-10-29 to 2020-10-29

Revenue in constant purchasing power

USD revenue expressed in 2026-08 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$29.43M$31.43M
2023-12-31$18.51M$20.35M
2022-12-31$12.40M$14.19M

Bureau of Labor Statistics · retrieved 2026-09-25 · 9 selected series; gaps remain missing

Explore the CPI history ↗